The Liver Lounge

Discover the latest insights in viral hepatitis control in Africa with Dr. Yusuke Shimakawa, a senior epidemiologist at the Institut Pasteur, Paris. In this episode, gain privileged access to Dr. Shimakawa's expertise as he navigates the complexities of hepatitis B and discusses tailored care strategies specifically for Africa. Tune in to deepen your understanding of this crucial public health issue.

We are thrilled to have the privilege of hosting Prof. Juan Pablo Arab, a distinguished expert in alcohol-associated liver disease from the Schulich School of Medicine at Western University, Canada. In this enlightening episode, Prof. Arab unveils groundbreaking insights from his recent publication in Hepatology, shedding light on the intricate molecular mechanisms underlying alcohol abstinence and relapse in individuals grappling with alcohol-associated liver disease. Prepare to be captivated as we explore the forefront of research with one of the foremost authorities in the field.

In this highly anticipated episode, we extend a warm welcome to Prof Rashid Lui, a distinguished gastrointestinal oncologist hailing from The Chinese University of Hong Kong. Join us as he delves into his comprehensive review on the pivotal role of the gut microbiome and fecal microbiota transplantation in addressing liver cancer and associated complications. Prof Lui offers captivating insights into the dynamic landscape of gut microbiome research, illuminating the path towards innovative approaches in liver health management.

Prepare for an enlightening journey as we dive into a riveting discussion with Prof Loretta Jophlin, an esteemed transplant hepatologist from the Trager Transplant Center, Jewish Hospital and the University of Louisville, Kentucky. Join us as she unveils invaluable insights into the latest ACG Clinical Guideline for Alcohol-Associated Liver Disease, offering a glimpse into cutting-edge advancements and best practices in liver health management.

We are truly honored to welcome a luminary in the field of hepatology, none other than Prof Kris Kowdley. With a career spanning decades, Prof Kowdley stands as a trailblazer in advancing our understanding of liver health. As the Director of Liver Institute Northwest and a distinguished Professor at Elson S Floyd College of Medicine at Washington State University, his expertise is unparalleled. Today, we have the distinct privilege of delving into his groundbreaking research, recently published in the prestigious New England Journal of Medicine, on the Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

We are delighted to host Prof Ana Lleo, a distinguished expert in autoimmune liver disease from Humanitas University. Join us for an enlightening discussion as we delve into her recent study published in the Journal of Hepatology. In this episode, we explore the intricacies surrounding the incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis. Don't miss out on the opportunity to gain valuable insights in this must-listen episode!

Join us for an exciting episode with Dr. Ciro Celsa from the Università degli Studi di Palermo as he unveils his latest research published in the Journal of Hepatology. Delve into the distinct characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to other advanced solid tumors. Don't miss this insightful discussion on the forefront of medical advancements.

Dive into the realm of transplant psychiatry with Dr. Zimbrean, Director of Transplant Psychiatry at Yale New Haven Hospital. With a focus on the mental health of organ transplant candidates, recipients, and donors, she shares insights from her latest study, 'Psychosocial Evaluation of Living Liver Donors: Current Practices in the U.S.' Join us for a concise and informative episode unraveling the intricacies of psychosocial evaluations for living donors.

Step into this episode with Dr. Pavel Strnad from the University Hospital Aachen, Germany. Leading a pioneering initiative on alpha-1 antitrypsin deficiency-associated liver disease, Dr. Strnad invites you to tune in and gain valuable insights into this crucial area of study. Don't miss the opportunity to delve into the world of alpha-1 antitrypsin deficiency-associated liver disease with a distinguished expert in the field.

In today’s episode, we are excited to welcome Dr Paul Brennan from University of Dundee. Join us as he unveils insights into his latest publication in Gut on the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm. Catch this exciting interview as he shares more about public health-directed policymaking and unique multi-disciplinary MASLD-centric referral pathways!

Step into an exclusive episode exploring blood-based biomarkers for hepatocellular carcinoma surveillance with the distinguished Professor Amit Singal from UT Southwestern Medical Center. As a leading authority in this field, Professor Singal boasts an impressive portfolio of over 200 publications in esteemed journals such as JAMA, Gastroenterology, Hepatology, Journal of Hepatology, and Gut. Additionally, Professor Singal also serves as an associate editor for Clinical Gastroenterology and Hepatology, and Seminars in Liver Disease. Don't miss this opportunity to gain valuable and unique perspectives from a distinguished expert in the field!

Discover the forefront of liver transplantation with Professor Michael Lucey, a leading expert and Medical Director of the UW Liver Transplant Program. Join us as Prof. Lucey delves into the depths of his recent study, featured in the prestigious New England Journal of Medicine, shedding light on the latest advancements and critical insights in the realm of liver transplantation. This episode promises to be an enlightening journey into the forefront of medical research and practice.

In this captivating episode, join us as we dive deep into the world of alcohol-associated liver disease with Elizabeth Lee, a highly skilled nurse practitioner from the University Health Network, Toronto General Hospital. With a wealth of experience in clinical practice, Elizabeth shares her insights on navigating the complexities in the care of patients with alcohol-associated liver disease. This episode is a must-listen for anyone interested in liver health and healthcare excellence.

Welcome to this episode featuring a rising star in the world of hepatology, Dr Luke Tyson, hailing from the prestigious St. Mary's Hospital and King's College Hospital. In this captivating episode, we delve into the world of hepatology with Dr. Tyson as he shares his groundbreaking research, a study titled “In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAs”, recently published in the esteemed Alimentary Pharmacology and Therapeutics. We explore the intersection of severe alcohol-related hepatitis and kidney injury, a topic of immense significance in the medical community. Tune in to discover the profound implications of this research, as we dissect its findings and implications.

In this episode, get ready to be inspired as we welcome the brilliant Professor Jagpreet Chhatwal, Director of the MGH Institute for Technology Assessment and Associate Professor at Harvard Medical School. His groundbreaking research in decision science, data analytics, health economics, and outcomes research has made waves in the medical world and even caught the attention of top media outlets. Join us as he unveils the sobering truth about the skyrocketing costs of alcohol-associated liver disease in the United States, as published in the American Journal of Gastroenterology.

In today’s episode, we are joined by Dr. Liv Hetland from Copenhagen University Hospital Hvidovre. Prepare to embark on a journey through her most recent research featured in Hepatology Communications where we explore the surprising challenges and limitations of ultrasound and CT scans in accurately diagnosing compensated cirrhosis.

It is our biggest privilege to introduce Prof Dr Manuel Romero-Gómez, the Head of Digestive Diseases Department at Virgen del Rocío University Hospitals and one of the leading global experts in NAFLD. With a remarkable portfolio of over 400 peer-reviewed papers dedicated to gastrointestinal and liver diseases, coupled with numerous accolades celebrating his outstanding contributions, Prof. Manuel Romero-Gómez is a trailblazer in his own right. In this episode, we embark on an illuminating journey with Prof. Romero-Gómez as he unveils his latest research recently published in the prestigious BMJ. He delves into the critical role of diet and nutrition in preventing NAFLD and the profound clinical implications of this work. Join us as we delve into the world of NAFLD with a true visionary, and discover how a proactive approach to diet and lifestyle can make a profound difference in liver health. This is an episode you won't want to miss!

Today, we are honoured to welcome Professor Jasmohan S. Bajaj from Virginia Commonwealth University, a prominent figure in the field of hepatology. He currently serves as the co-editor-in-chief of the American Journal of Gastroenterology and chair for the North American Consortium for Study of End-Stage Liver Disease. In this episode, Professor Jasmohan dives into his groundbreaking study recently published in The Lancet Gastroenterology & Hepatology. This study, conducted by the CLEARED Consortium, sheds light on global disparities in mortality and liver transplantation among hospitalized patients with cirrhosis. Join us as we explore the critical findings and their implications for global healthcare.

We are honored and ecstatic to introduce Professor Jeffrey Lazarus, a luminary in the field of global public health. As the working group chair of the EASL-Lancet European Liver Health Commission, and the recipient of numerous prestigious awards for his tireless dedication to advancing global health agendas, Professor Jeffrey stands at the forefront of the international stage. Recently, he led the charge in crafting the Delphi consensus statement, a milestone achievement in reshaping the nomenclature of fatty liver disease. In this awe-inspiring episode, we delve deep into the heart of a global public health movement aimed at tackling the monumental challenge of Metabolic Associated Steatotic Liver Disease (MASLD). Join us as we unlock profound insights that are reshaping the landscape of global health.

Welcome to this episode featuring Prof. Lizzie Aby, a distinguished transplant hepatologist hailing from the University of Minnesota, United States. Prof. Aby has been honored with the prestigious advanced/transplant hepatology award from AASLD, making her a leading authority in her field. Join us as we delve into her recent publication in Hepatology Communications, shedding light on the compelling topic of high rifaximin out-of-pocket costs and their influence on treatment retention among patients grappling with hepatic encephalopathy. Tune in to discover the profound implications of this research, as we dissect its findings and implications.

Want some clinical pearls on the effective management of liver cirrhosis? In this enlightening episode, join us as we sit down with Dr. Dina Mansour, Liver Committee Secretary at the British Society of Gastroenterology and a renowned expert at Queen Elizabeth Hospital. Together, we distill the latest guidelines for the effective management of liver cirrhosis. Dr. Mansour's expertise shines as she navigates through the nuanced and contentious aspects of cirrhosis care, offering invaluable insights. This episode is a must-listen for all dedicated liver physicians, providing essential knowledge and guidance for those who compassionately manage cirrhotic patients in their daily practice. Don't miss this opportunity to elevate your cirrhosis management skills!

In this episode, we are honored to have Professor Shadab Siddiqui from Virginia Commonwealth University, a trailblazing figure in the realm of steatotic liver disease and liver transplantation. Buckle up for an exploration of the complexities surrounding liver transplantation within the context of NASH cirrhosis. This episode offers a treasure trove of expertise and intrigue that simply cannot be overlooked!

In this exciting episode, we are joined by Dr. Anahita Rabiee from Yale New Haven Hospital. Our conversation delves into her latest research, featured in Hepatology Communications, where she explores the positive impact of medications for alcohol use disorder on the survival of individuals dealing with hazardous drinking and alcohol-associated cirrhosis. Join us as Dr. Anahita Rabiee shares her insights on effectively managing patients with alcohol-associated liver disease!

In this captivating episode, we are honoured to host Dr Vincent Chen, a renowned hepatologist from the University of Michigan Health. Dr Vincent’s interest and expertise lies in the progression of steatotic liver disease. In particular, he explores the use of biomarkers and genetics in the risk stratification of patients at risk of progression to cirrhosis and decompensation which has profound clinical impact and translational value. Tune in to catch valuable clinical pearls and gain profound insights on a complex topic!

Join us in this podcast episode as we delve into the rich expertise of Professor George Ioannou who is the Director of Hepatology at the Seattle VA. With a dedicated focus on liver disease and veteran healthcare, Professor Ioannou brings to light his profound insights and wisdom. Notably, he is also the author of the enlightening book 'Kintsugi Medicine in the Veterans Health Administration'. Tune in to gain a deep understanding of his extensive experience in the realms of liver disease and healthcare for veterans.

Prepare to be enthralled in this mesmerizing episode, featuring none other than Prof Sigh Pichamol Jirapinyo, an advanced endoscopist and bariatric endoscopist at Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, where she also serves as Director of Bariatric Endoscopy Fellowship and Associate Director of Bariatric Endoscopy. Sit back and enjoy Prof Jirapinyo’s profound clinical and research mastery in the captivating realm of endo-hepatology.

Buckle up for an electrifying episode as Dr. David Marti-Aguado deep dives into his latest groundbreaking research in the field of alcohol-associated liver disease. In this riveting episode, he unfurls the ingenious strategies that confront the formidable challenge of alcohol withdrawal syndrome in the context of alcohol-associated hepatitis. Tune in as we dissect the very essence of managing this high-stakes interplay between alcohol withdrawal and liver health.

In this captivating episode, listeners are presented with the esteemed presence of Dr. Daniel Huang, a distinguished luminary in the field of HCC-related research. The episode gracefully navigates through cutting-edge advancements in surveillance strategies, offering a profound understanding of the subject. Furthermore, it delves into the intricate challenges posed by NAFLD-HCC, hear what Dr Huang has to say about the subject!

In this insightful episode, we have the pleasure of hearing from Dr. Michael Tseng, currently a first-year GI fellow at MedStar Georgetown University Hospital. Dr. Tseng generously walks us through his personal journey of successfully securing a spot in a gastrointestinal fellowship program. His candid narrative not only offers a peek into his own experiences, but also extends a helping hand to those navigating the intricate process of fellowship matching. From his initial fascination with gastroenterology to the meticulous planning and hard work that paved his way to success, Dr. Tseng's story is both motivating and enlightening. Beyond recounting his journey, he graciously imparts practical tips and wisdom for individuals aspiring to tread a similar path in the medical realm.

In this podcast episode, we spotlight Professor Mazen Noureddin, esteemed director of the Houston Research Institute. Join us as we explore the far-reaching implications of the updated nomenclature for non-alcoholic fatty liver disease (NAFLD), now known as metabolic associated steatotic liver disease (MASLD). Professor Noureddin's expertise navigates beyond terminology, shedding light on how this shift influences medical understanding, patient care, and public health policies. Tune in for an insightful journey into the world of hepatology and its impact on our well-being.